IMRA

Imara Inc.

Price

$14.88

return (12m)

p/e

67.48

p/bv

1.18

DIVIDEND YIELD

114.25%

IMRA price

Imara

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IMRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals IMRA

Valuation

P/E

67.48

Sector -2.34

Industry -6.52

P/BV

1.18

Sector 2.17

Industry 1.78

P/Revenue (PSR)

Sector 2.00

Industry 3.10

EV/EBITDA

-5.44

Sector -23.69

Industry -28.17

EV/EBIT

-5.44

Sector -36.60

Industry -41.91

P/EBITDA

-3.15

Sector -0.10

Industry -3.02

P/EBIT

-3.09

Sector -2.08

Industry -5.99

P/Total Assets

1.15

Sector 1.18

Industry 1.22

P/Net Current Assets

1.21

Sector -10.91

Industry -7.72

P/Working Capital

1.21

Sector 0.09

Industry 0.93

EPS

0.22

Sector -0.93

Industry -1.40

BVPS

12.88

Sector 3.87

Industry 1.97

Efficiency

Gross Margin

0.00%

Sector 44.28%

Industry 46.71%

EBITDA Margin

Sector -291.45%

Industry -17,446,152.48%

EBIT Margin

Sector -195.44%

Industry -17,707,972.85%

Operating Margin

0.00%

Sector -25.72%

Industry -34.74%

Net Profit Margins

0.00%

Sector -30.19%

Industry -38.14%

Asset Turnover

0.00

Sector 0.12

Industry 0.05

Profitability

ROE

1.74%

Sector -34.71%

Industry -50.12%

ROA

1.71%

Sector -28.76%

Industry -54.08%

ROIC

-724.58%

Sector -441.27%

Industry -529.87%

Dividends

Dividend yield

114.25%

Sector -

Industry -

Payout

7,709.59%

Sector -

Industry -

Debt

Current Ratio

48.98

Sector 1.87

Industry 2.30

Net Debt / EBITDA

27.06

Sector -2.18

Industry 0.95

Net Debt / EBIT

27.06

Sector -0.74

Industry -0.05

Net Debt / Equity

-0.98

Sector -0.34

Industry -0.49

Gross Debt / Equity

0.00

Sector -0.64

Industry 0.03

Equity/Assets

0.98

Sector 0.43

Industry 0.46

Liabilities/Assets

0.02

Sector 0.46

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Imara ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$14.88

Fair Value

$7.98

Upside Return potential.

-46.34%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IMRA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IMRA Imara Inc.	$14.88	-	114.25%	67.48	1.18	1.74%	0.00%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IMRA Historical Dividends

current DY: 114.25%

5-year average DY: 114.25%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/27/2026	03/03/2026	0.30590000
Dividends	01/23/2026	01/27/2026	0.20800000
Dividends	12/26/2025	12/30/2025	1.41700000
Dividends	11/28/2025	12/02/2025	1.69400000
Dividends	10/24/2025	10/28/2025	3.01200000
Dividends	09/26/2025	09/30/2025	3.20000000
Dividends	08/22/2025	08/26/2025	2.90000000
Dividends	07/25/2025	07/29/2025	3.86500000
Dividends	06/27/2025	07/01/2025	1.89000000
Dividends	05/23/2025	05/28/2025	9.33000000

ABOUT Imara

Imara Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

10 years

Founded: 2016

2020

Time since IPO - 6 years

27

Employees

Imara Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $105.94 million, with shareholders equity totaling $90.13 million.

The company employs approximately 27 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, Imara Inc. reported $- in revenue, generating net income of $1.57 million.

Key financial metrics include a P/E ratio of 67.48, a price-to-book (P/B) ratio of 1.18, and a trailing twelve-month dividend yield of 114.25%.

The company trades under the ticker IMRA.

Market cap

$105.94 million

Net worth

$90.13 million

$90,130,000.00

Assets

$91.96 million

$91,960,000.00

Total Shares Outstanding

7.00 million

7,000,000

Average Daily Trading Volume

$4.00 Thousand

$3,997.22

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

IMRA

IMRA revenue and profits

Financial Results IMRA

DRAG THE FRAME TO SEE MORE DATA

IMRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56